Ghada Eladly/LinkedIn
Jun 11, 2026, 15:48
Ghada Eladly: The Classic Triad of Hemolytic Uremic Syndrome
Ghada Eladly, Senior ICU Clinical Pharmacist at Ain Shams University Specialized Hospital, shared a post on LinkedIn:
“Hemolytic Uremic Syndrome (HUS)
Definition: Hemolytic Uremic Syndrome characterized by microvascular thrombosis.
Classic Triad:
- MAHA: Microangiopathic hemolytic anemia.
- Thrombocytopenia: Platelet consumption.
- AKI: Acute kidney injury due to renal microthrombi.
- Pathophysiology: Endothelial injury leads to platelet activation, resulting in microthrombi formation.
- Common Cause: Shiga toxin–producing E. coli (post-diarrheal HUS).”
Stay updated with Hemostasis Today.
-
Sep 12, 2026, 17:55Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
-
Sep 12, 2026, 17:49Kalyan Roy: TRAGS – An Emerging Transfusion Safety Concern
-
Sep 12, 2026, 17:48Jason Fung: What Happened to “Statins Save Lives”?
-
Sep 12, 2026, 17:47Eric Topol: Most Supplements and Vitamins Offer Little Proven Benefit
-
Sep 12, 2026, 17:44Manuel Monreal: Clinical Characteristics, Treatment, and Outcomes in Hispanic vs Caucasian Patients With VTE
-
Sep 12, 2026, 17:43Sidi Mohamed El Amine Benlazar: CPX-351 and Ruxolitinib in Advanced-Phase Myeloproliferative Neoplasms